BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22701711)

  • 1. TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain.
    Jung YS; Liu XW; Chirco R; Warner RB; Fridman R; Kim HR
    PLoS One; 2012; 7(6):e38773. PubMed ID: 22701711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells.
    D'Angelo RC; Liu XW; Najy AJ; Jung YS; Won J; Chai KX; Fridman R; Kim HR
    Mol Cancer Res; 2014 Sep; 12(9):1324-33. PubMed ID: 24895412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells.
    Yang CC; Zhu LF; Xu XH; Ning TY; Ye JH; Liu LK
    BMC Cancer; 2013 Apr; 13():171. PubMed ID: 23548172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1.
    Ota I; Li XY; Hu Y; Weiss SJ
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20318-23. PubMed ID: 19915148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells.
    Chernov AV; Sounni NE; Remacle AG; Strongin AY
    J Biol Chem; 2009 May; 284(19):12727-34. PubMed ID: 19286653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.
    Lin CY; Tsai PH; Kandaswami CC; Lee PP; Huang CJ; Hwang JJ; Lee MT
    Cancer Sci; 2011 Apr; 102(4):815-27. PubMed ID: 21219539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer.
    Nguyen HL; Kadam P; Helkin A; Cao K; Wu S; Samara GJ; Zhang Q; Zucker S; Cao J
    Curr Cancer Drug Targets; 2016; 16(7):618-30. PubMed ID: 26881932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
    Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
    Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-destructive and selective imaging of the functionally active, pro-invasive membrane type-1 matrix metalloproteinase (MT1-MMP) enzyme in cancer cells.
    Remacle AG; Shiryaev SA; Golubkov VS; Freskos JN; Brown MA; Karwa AS; Naik AD; Howard CP; Sympson CJ; Strongin AY
    J Biol Chem; 2013 Jul; 288(28):20568-80. PubMed ID: 23733191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases and their inhibitors in canine mammary tumors.
    Aresu L; Giantin M; Morello E; Vascellari M; Castagnaro M; Lopparelli R; Zancanella V; Granato A; Garbisa S; Aricò A; Bradaschia A; Mutinelli F; Dacasto M
    BMC Vet Res; 2011 Jul; 7():33. PubMed ID: 21726449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment.
    Lee MH; Atkinson S; Rapti M; Handsley M; Curry V; Edwards D; Murphy G
    Cancer Lett; 2010 Apr; 290(1):114-22. PubMed ID: 19815335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
    Wang C; Chen Z; Li Z; Cen J
    Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis.
    Aplin AC; Zhu WH; Fogel E; Nicosia RF
    Am J Physiol Cell Physiol; 2009 Aug; 297(2):C471-80. PubMed ID: 19494241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses.
    Pang L; Li Q; Li S; He J; Cao W; Lan J; Sun B; Zou H; Wang C; Liu R; Wei C; Wei Y; Qi Y; Hu J; Liang W; Zhang WJ; Wan M; Li F
    Sci Rep; 2016 Feb; 6():22179. PubMed ID: 26916665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
    Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
    Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
    J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.